Hikal Limited (NSE:HIKAL)
188.20
-0.94 (-0.50%)
Apr 30, 2026, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 23.41 billion as of May 1, 2026. Its market cap has decreased by -52.36% in one year.
Market Cap
23.41B
Enterprise Value
30.05B
Revenue
17.46B
Ranking
n/a
PE Ratio
n/a
Stock Price
188.20
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 23.41B, an increase of 1,624.77%. That is a compound annual growth rate of 12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 23.41B | -16.33% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 48.21B |
| Innova Captab | 41.68B |
| RPG Life Sciences | 33.58B |
| Orchid Pharma | 31.08B |
| Solara Active Pharma Sciences | 23.64B |
| Indoco Remedies | 19.34B |
| Windlas Biotech | 17.93B |
| Jagsonpal Pharmaceuticals | 14.02B |